Agencies, 12 April: India’s Subject Expert Committee para Dr. Reddy’s application mana toh Russia laga Sputnik V Covid-19 dawai te emergency use authorisation nemite ase.
Etu toh India te emergency use nemite mana third dawai ase. Etu agae te tuita locally bona dawai – Bharat Biotech’s Covaxin aro Oxford-Astrazeneca’s Covishield – nemite mana thakise.
Russia laga Sputnik V nemite mana toh desh te COVID-19 dawai doses komti howa opor te besi states khan para monchinda howa janaideya bechite ase.
India para aro 5 COVID dawai October 2021 para bonabo
Central government para fesla korise dawai te komti hoi thaka nemite COVID-19 dawai bona toh joldi koribole nemite. Government sources hisab te, India te five extra manufacturers para dawai toh October 2021 para pabole bhabona ase aro etu te Russia’s Sputnik V COVID-19 be melikena ase aro etu toh emergency nod nemite powa be pai kena ase.
India te 2021 laga third quarter para local aro five dawai bonabole bhabona kora khan– Sputnik V, Johnson & Johnson vaccine, Novavax vaccine, Zydus Cadila’s vaccine aro Bharat Biotech’s Intranasal Vaccine ase.
Union government toh emergency use authorisation (EUA) nemite namana agae te, COVID-19 dawai te safety aro efficacy nemite focus ase.
Besi phak 20 COVID-19 dawai toh desh (India) te alak alak clinical aro pre-clinical stages te ase.
Russia’s Sputnik V vaccine toh tai khan majote emergency nod powa first hoise.
Russian Direct Investment Fund (RDIF) toh locally vaccine doses bonabo nemite besi local Indian pharmaceutical players- Hyderabad based Dr. Reddy’s Laboratories, Hetero Biopharma, Gland Pharma, Stelis Biopharma aro Vichrow Biotech nesana khan logote melishe.
Add Comment